chr10-48171085-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_001018071.4(FRMPD2):c.3347C>T(p.Pro1116Leu) variant causes a missense change. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 23)
Exomes 𝑓: 0.00011 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FRMPD2
NM_001018071.4 missense
NM_001018071.4 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 4.78
Genes affected
FRMPD2 (HGNC:28572): (FERM and PDZ domain containing 2) This gene encodes a peripheral membrane protein and is located in a region of chromosome 10q that contains a segmental duplication. This copy of the gene is full-length and is in the telomeric duplicated region. Two other more centromerically proximal copies of the gene are partial and may represent pseudogenes. This full-length gene appears to function in the establishment and maintenance of cell polarization. The protein is recruited to cell-cell junctions in an E-cadherin-dependent manner, and is selectively localized at the basolateral membrane in polarized epithelial cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRMPD2 | NM_001018071.4 | c.3347C>T | p.Pro1116Leu | missense_variant | 26/29 | ENST00000374201.8 | |
FRMPD2 | NM_001318191.1 | c.3272C>T | p.Pro1091Leu | missense_variant | 24/27 | ||
FRMPD2 | NM_001042512.3 | c.380C>T | p.Pro127Leu | missense_variant | 3/6 | ||
FRMPD2 | XM_017015744.2 | c.203C>T | p.Pro68Leu | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRMPD2 | ENST00000374201.8 | c.3347C>T | p.Pro1116Leu | missense_variant | 26/29 | 1 | NM_001018071.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 31AN: 146880Hom.: 0 Cov.: 23 FAILED QC
GnomAD3 genomes
AF:
AC:
31
AN:
146880
Hom.:
Cov.:
23
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000560 AC: 2AN: 35742Hom.: 0 AF XY: 0.000109 AC XY: 2AN XY: 18270
GnomAD3 exomes
AF:
AC:
2
AN:
35742
Hom.:
AF XY:
AC XY:
2
AN XY:
18270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000111 AC: 76AN: 685856Hom.: 0 Cov.: 9 AF XY: 0.0000984 AC XY: 36AN XY: 365936
GnomAD4 exome
AF:
AC:
76
AN:
685856
Hom.:
Cov.:
9
AF XY:
AC XY:
36
AN XY:
365936
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000211 AC: 31AN: 146998Hom.: 0 Cov.: 23 AF XY: 0.000210 AC XY: 15AN XY: 71286
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
31
AN:
146998
Hom.:
Cov.:
23
AF XY:
AC XY:
15
AN XY:
71286
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2022 | The c.3347C>T (p.P1116L) alteration is located in exon 26 (coding exon 26) of the FRMPD2 gene. This alteration results from a C to T substitution at nucleotide position 3347, causing the proline (P) at amino acid position 1116 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;D
REVEL
Benign
Sift
Uncertain
.;D;D
Sift4G
Pathogenic
.;D;D
Polyphen
0.83, 0.58
.;P;P
Vest4
0.45, 0.47
MutPred
Gain of catalytic residue at P1116 (P = 0.0254);Gain of catalytic residue at P1116 (P = 0.0254);.;
MVP
0.55
MPC
2.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at